Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Nov 24, 2021 11:18am
177 Views
Post# 34161588

what will they say under oath during discovery in 2022 when

what will they say under oath during discovery in 2022 when lawyers ask them    you stated that you tried all options to raise money please show us proof of all options you tried; why didn't you do rights offering monthsss before     since you raised 38 million AFTER YOU WIPED OUT RETAIL INVESTORS  IMAGINE HOW MUCH THEY WOULD HAVE RAISED BEFORE 

it will become clear  that they didn't want to raise money since they would not have met criteria for hardship at tsx AND THIS WOULD HAVE BLOCKED THEIR TAKEOVER 
<< Previous
Bullboard Posts
Next >>